In response to the growing need for high quality RNAi agent delivery mediums, Bioo Scientific presents MaxSuppressor In Vivo RNA-Lancer II
After extensive animal validation testing, we have identified a new in vivo delivery vehicle that has demonstrated significant value for gene knockdown in mice and rats.
MaxSuppressor In Vivo RNA-Lancer II (catalogue #3410-01) has drastically outperformed all other delivery agents tested.
MaxSuppressorT In Vivo RNA-Lancer II uses a set of neutral hydrophobic molecules to encapsulate and deliver RNAi agents into tissues achieving maximal gene reduction with minimal amounts of RNAi agent.
This patent-pending formulation has utility for in vivo target validation and therapeutic agent development.
The procedure takes about one hour and can be performed in any laboratory setting.
